NCT07639203

Brief Summary

The study, entitled "PotenziaMente: Cognitive Training in Aging," is a clinical trial designed to evaluate the effectiveness of an individualized tablet-based cognitive training program targeting executive functions (e.g., planning, cognitive flexibility, and problem solving) in healthy older adults. Executive functions are higher-order cognitive processes that support adaptive functioning in daily life and influence other cognitive domains, such as memory. The primary aim of the study is to enhance cognitive performance, specifically executive functioning, in neurologically healthy adults aged 65 to 75 years. A secondary aim is to compare the effects of two different delivery modalities of the same cognitive training program: home-based self-administration via tablet versus supervised tablet-based training in the presence of a trained researcher. Participants will undergo cognitive assessments at baseline (pre-training), immediately after the intervention (post-training), and at a 3-month follow-up. This is a randomized parallel-group interventional clinical trial without masking. Participants are randomly assigned to one of two groups: a home-based cognitive training condition, in which they perform an individualized tablet-based cognitive training program targeting executive functions independently at home via a tablet application without direct supervision, or a supervised cognitive training condition, in which they perform the same individualized tablet-based cognitive training under the supervision of a trained researcher in a controlled environment. The intervention consists of two sessions per week, 1 hour per session, for 4 consecutive weeks, delivered via tablet-based exercises. The study uses a parallel assignment model with a prospective design and a primary purpose of treatment (cognitive enhancement and prevention of cognitive decline). The primary outcome is the change in executive functioning from baseline to post-intervention, assessed using standardized neuropsychological tests. Secondary outcomes include between-group differences (home-based vs. supervised) in executive functioning, changes in global cognitive functioning from baseline to post-intervention, and maintenance of cognitive effects at the 3-month follow-up.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
1mo left

Started Sep 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Sep 2024Sep 2026

Study Start

First participant enrolled

September 17, 2024

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

June 5, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 10, 2026

Completed
20 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Expected
Last Updated

July 10, 2026

Status Verified

May 1, 2026

Enrollment Period

1.8 years

First QC Date

June 5, 2026

Last Update Submit

July 8, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • The Tower of London Test (Bruni et al. 2020)

    Accuracy and timing

    0-4 months

  • Frontal Assessment Battery (Apollonio et al., 2005)

    Minimum value: 0; Maximum value: 18; Higher scores indicate better executive functioning.

    0-4 months

Study Arms (2)

Remote Cognitive Training

EXPERIMENTAL

A group of participants randomly assigned to a remote tablet-based cognitive training intervention through individualized training sessions aimed at improving cognitive performance.

Behavioral: Remote Cognitive Training

Supervised In-Person Cognitive Training

ACTIVE COMPARATOR

A group of participants randomly assigned to an in-person supervised tablet-based cognitive training intervention consisting of individualized training sessions aimed at improving cognitive performance.

Behavioral: Supervised In-Person Cognitive Training

Interventions

A 4-week tablet-based cognitive training intervention targeting executive functions in healthy older adults. Participants complete 2 individualized training sessions per week (1 hour each), delivered remotely via email and performed independently at home using a tablet. The intervention focuses on enhancing executive functioning, including planning, cognitive flexibility, and problem solving, with the aim of improving overall cognitive performance in daily life.

Remote Cognitive Training

A 4-week tablet-based cognitive training intervention targeting executive functions in healthy older adults. Participants complete 2 individual training sessions per week (1 hour each), delivered in person under the supervision of a trained researcher in a controlled environment. The intervention focuses on enhancing executive functioning, including planning, cognitive flexibility, and problem solving, with the aim of improving overall cognitive performance in daily life.

Supervised In-Person Cognitive Training

Eligibility Criteria

Age65 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Cognitively healthy adults aged 65 to 75 years. Montreal Cognitive Assessment (MoCA) equivalent score ≥ 1, according to Italian normative values.

You may not qualify if:

  • History of current or previous neurological or neuropsychiatric disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro Interdipartimentale Mente/Cervello - CIMeC

Rovereto, Trento, 38068, Italy

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Study Director

Study Record Dates

First Submitted

June 5, 2026

First Posted

June 10, 2026

Study Start

September 17, 2024

Primary Completion

June 30, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

July 10, 2026

Record last verified: 2026-05

Locations